The results showed no Progenza-related safety or toxicity issues, even at doses well in excess of the intended human dose. Further, Progenza-treated knees showed no deterioration from the time of injection, in contrast to the vehicle control group, which continued to deteriorate over the 7-week study.
http://ift.tt/1wkzKnk
http://ift.tt/1wkzKnk
No comments:
Post a Comment